STOCK TITAN

Henry Schein Inc - HSIC STOCK NEWS

Welcome to our dedicated page for Henry Schein news (Ticker: HSIC), a resource for investors and traders seeking the latest updates and insights on Henry Schein stock.

Henry Schein Inc. (symbol: HSIC) is the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners. As a Fortune 500® company and a member of the S&P 500® and NASDAQ 100® indexes, Henry Schein employs more than 18,000 team members and serves over one million customers globally. The company's offerings extend to dental laboratories, government and institutional healthcare clinics, and other alternate care sites.

Henry Schein operates through a centralized and automated distribution network, offering a comprehensive selection of more than 100,000 branded products and private-label products, as well as over 150,000 additional products available as special-order items.

The company is organized into two main segments: Healthcare Distribution and Technology & Value-Added Services. The Healthcare Distribution segment focuses on distributing consumable products, small equipment, and laboratory products. The Technology & Value-Added Services segment provides innovative software solutions and other technology services designed to help healthcare practitioners run their practices more efficiently and deliver high-quality care.

In recent years, Henry Schein has achieved significant milestones, including expanding its product range and forming strategic partnerships to enhance its service offerings. The company continues to innovate with exclusive technology solutions aimed at improving practice management and patient care.

Rhea-AI Summary

Henry Schein, the largest provider of healthcare solutions for dental and medical practitioners, has acquired a majority stake in Biotech Dental S.A.S., a growing provider of dental implants and software based in France. Announced on December 16, 2022, this acquisition aims to enhance Henry Schein's digital dental solutions portfolio. Biotech Dental's offerings include innovative software for planning and diagnostics, and its revenue was approximately $100 million in 2022. The acquisition is expected to slightly dilute earnings per share in 2023 due to non-cash adjustments. Both companies aim to improve clinical outcomes and streamline workflows for dental professionals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.89%
Tags
partnership
-
Rhea-AI Summary

Henry Schein, Inc. (NASDAQ: HSIC) announced its participation in the 2023 ADSO Annual Summit in Orlando, Florida, from March 28-31. The event focuses on shaping the future of dentistry through discussions on intrapreneurship and procurement innovations. Key executives, including CEO Stanley Bergman, will share insights into the evolving dental landscape. Additionally, the company's corporate social responsibility program will host a hygiene kit-packing event to aid those affected by global crises. With $12.6 billion in sales in 2022, Henry Schein continues to be a leader in health care solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.01%
Tags
none
-
Rhea-AI Summary

Henry Schein (Nasdaq: HSIC) will host a pre-conference program on March 28 from 2:30 – 5:30 PM at the 2023 ADSO Annual Summit in Melville, N.Y.. The program, titled “Innovative Solutions for Unprecedented Times,” features CEO Stanley Bergman and Jeannie Diefenderfer from the Higher Ambition Leadership Alliance. Discussions will focus on leveraging technology and purpose-driven business strategies to enhance practice performance.

The event includes a keynote by Silvia Vasquez-Lavado and aims to connect group practice leaders with innovative solutions to improve patient care and business success.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.41%
Tags
conferences
Rhea-AI Summary

Henry Schein Inc. has integrated AI technologies into its cloud-based practice management software, Dentrix Ascend, enhancing efficiency in dental practices. The new features include Dentrix Ascend Detect AI, an FDA-cleared tool for real-time X-ray analysis that aids in diagnosis and treatment recommendations, improving case acceptance and patient care. The Dentrix Ascend Voice tool enables faster data entry through voice recognition, thereby increasing productivity during exams. This integration is part of Henry Schein's commitment to leverage AI for better patient outcomes and operational efficiency.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.01%
Tags
none
-
Rhea-AI Summary

Henry Schein Inc. (NASDAQ: HSIC) will present its innovative solutions during the 2023 International Dental Show in Cologne, Germany, from March 14 to 18, 2023. CEO Stanley M. Bergman will lead a media briefing on digital dentistry advancements, focusing on integration of data, devices, and software. The company will exhibit a broad range of healthcare solutions aimed at enhancing dental practice efficiency and patient care. Notable products include orthodontic supplies, dental handpieces, surgical supplies, and minimally invasive solutions. Special presentations by industry leaders such as Prof. Irena Sailer and Prof. Gianluca Gambarini will also take place throughout the event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.27%
Tags
none
-
Rhea-AI Summary

Henry Schein has been named one of the 2023 World’s Most Ethical Companies by Ethisphere, marking the 12th consecutive year of recognition. The company, which specializes in health care solutions for dental and medical practitioners, is the sole honoree in the Healthcare Products industry. This year, 135 companies were recognized across 19 countries and 46 industries. CEO Stanley M. Bergman emphasized the company's commitment to stakeholders and social responsibility, addressing issues like climate change and health equity. Henry Schein's sales reached $12.6 billion in 2022, exhibiting a compound annual growth rate of approximately 12.1% since its IPO in 1995.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
none
Rhea-AI Summary

Henry Schein (NASDAQ: HSIC) will sponsor keynote speaker Erica Dhawan at the 2023 Women in DSO® event from March 8-10, 2023, in Las Vegas. Dhawan, a renowned authority on collaboration and innovation, will speak on March 9. As a founding supporter of Women in DSO®, Henry Schein aims to promote female leadership in the dental sector. The company emphasizes creating an inclusive environment by partnering with organizations that align with this mission. Notably, Henry Schein was awarded the Women’s Choice Award for Best Companies to Work For, reflecting its commitment to diversity and empowerment.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.72%
Tags
none
-
Rhea-AI Summary

Henry Schein, Inc. (Nasdaq: HSIC) hosted an Investor Meeting in New York City to present its BOLD+1 Strategic Plan aimed at sustainable growth and long-term financial goals. CEO Stanley Bergman highlighted the company's transformation since 1995 into a leading global health care distribution provider. The plan focuses on digital transformation, revenue growth in specialty products, and ESG investments. Management discussed recent financial guidance and market growth opportunities, affirming their commitment to shareholder value. The event was streamed live, with materials available on their investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.04%
Tags
none
-
Rhea-AI Summary

Henry Schein, along with its dental laboratory business Zahn Dental, is actively participating in key events at the Chicago Dental Society Midwinter Meeting. The agenda includes a keynote presentation by Stanley M. Bergman, focused on growth drivers like dental implants and advancements in technology, including 3D printing. The events aim to enhance relationships with dental laboratories and support digital adoption. Attendees will benefit from educational sessions, product demonstrations, and discussions on integrating digital workflows. Zahn Dental expects to reach over 1,000 lab technicians at the LMT LAB DAY, providing hands-on experience with innovations like the 3D printer TRUJETX3™.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.86%
Tags
none
Rhea-AI Summary

Henry Schein (Nasdaq: HSIC) announced its participation in the Barclays Global Healthcare Conference on March 14, 2023, at 1:35 p.m. Eastern time in Miami, Florida. This conference will showcase Henry Schein's role as the world’s largest provider of health care solutions for office-based dental and medical practitioners. Investors can access the presentation through a live webcast on the company's website, which will be available for replay afterward. With over 22,000 Team Schein Members, Henry Schein offers more than 300 solutions supporting 1 million customers, highlighting a sales revenue of $12.6 billion in 2022.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
conferences

FAQ

What is the current stock price of Henry Schein (HSIC)?

The current stock price of Henry Schein (HSIC) is $69.82 as of December 20, 2024.

What is the market cap of Henry Schein (HSIC)?

The market cap of Henry Schein (HSIC) is approximately 8.7B.

What does Henry Schein Inc. do?

Henry Schein Inc. provides healthcare products and services to office-based dental, animal health, and medical practitioners, as well as other care sites.

How many team members does Henry Schein employ?

Henry Schein employs more than 18,000 team members.

What segments does Henry Schein operate in?

Henry Schein operates in two main segments: Healthcare Distribution and Technology & Value-Added Services.

How many products does Henry Schein offer?

Henry Schein offers a selection of more than 100,000 branded and private-label products, and over 150,000 additional products as special-order items.

Who are Henry Schein's primary customers?

Henry Schein's primary customers are office-based dental, animal health, and medical practitioners, dental laboratories, and institutional health care clinics.

What kind of technology solutions does Henry Schein provide?

Henry Schein provides innovative software and technology solutions to help healthcare practitioners manage their practices efficiently.

Is Henry Schein a Fortune 500 company?

Yes, Henry Schein is a Fortune 500® company.

What stock market indexes is Henry Schein a part of?

Henry Schein is a member of the S&P 500® and NASDAQ 100® indexes.

How many customers does Henry Schein serve?

Henry Schein serves over one million customers worldwide.

Does Henry Schein have any recent achievements?

Henry Schein has expanded its product range and formed strategic partnerships to enhance its service offerings in recent years.

Henry Schein Inc

Nasdaq:HSIC

HSIC Rankings

HSIC Stock Data

8.71B
123.38M
0.9%
107.44%
4.98%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States of America
MELVILLE